Viewing Study NCT03480750


Ignite Creation Date: 2025-12-24 @ 5:03 PM
Ignite Modification Date: 2026-01-29 @ 9:28 PM
Study NCT ID: NCT03480750
Status: COMPLETED
Last Update Posted: 2020-11-10
First Post: 2018-03-02
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Trial of Trientine Plus Pegylated Liposomal Doxorubicin and Carboplatin in Epithelial Ovarian Cancer
Sponsor: National Cheng-Kung University Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Neoplasms Malignant (Excl Germ Cell) View
None Peritoneal Carcinoma View
None Fallopian Tube Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Copper chelator View
None Epithelial ovarian cancer View
None Tubal cancer View
None Peritoneal cancer View
None Trientine View
None Pegylated liposomal doxorubicin View
None Carboplatin View